Zealand Pharma A/S
ZLDPF
$62.50
-$0.79-1.25%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.14B | 1.27B | 1.28B | 469.14M | 242.18M |
| Total Receivables | 40.40M | 24.85M | 16.98M | 8.61M | 20.58M |
| Inventory | 1.49M | 120.10K | 115.40K | 421.90K | 1.18M |
| Prepaid Expenses | -- | 5.21M | 8.67M | 6.69M | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 5.32M | 5.11M | 5.16M | -- |
| Total Current Assets | 1.18B | 1.30B | 1.31B | 490.03M | 263.94M |
|
|
|||||
| Total Current Assets | 1.18B | 1.30B | 1.31B | 490.03M | 263.94M |
| Net Property, Plant & Equipment | 17.39M | 19.28M | 21.02M | 21.36M | 22.22M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 1.75M | 1.73M | 1.72M | 1.68M | 1.82M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.83M | 3.71M | 1.81M | 2.55M | 2.48M |
| Total Assets | 1.32B | 1.44B | 1.46B | 518.76M | 293.63M |
|
|
|||||
| Total Accounts Payable | 25.17M | 34.35M | 32.66M | 37.69M | 13.59M |
| Total Accrued Expenses | 13.00M | -- | -- | -- | 7.67M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.23M | 2.38M | 4.29M | 2.16M | 2.47M |
| Total Finance Division Other Current Liabilities | 15.62M | -- | -- | -- | 18.48M |
| Total Other Current Liabilities | 15.62M | -- | -- | -- | 18.48M |
| Total Current Liabilities | 56.01M | 36.74M | 36.95M | 39.85M | 42.20M |
|
|
|||||
| Total Current Liabilities | 56.01M | 36.74M | 36.95M | 39.85M | 42.20M |
| Long-Term Debt | 39.61M | 42.03M | 39.77M | 39.43M | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 12.55M | 13.84M | 11.98M | 14.70M | 15.21M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 15.22M | 19.07M | 20.43M | 14.33M | -- |
| Total Liabilities | 123.39M | 111.68M | 109.12M | 108.31M | 57.41M |
|
|
|||||
| Common Stock & APIC | 2.05B | 2.21B | 2.12B | 1.15B | 958.74M |
| Retained Earnings | -854.79M | -881.14M | -772.34M | -738.39M | -725.89M |
| Treasury Stock & Other | 3.11M | 3.40M | 3.26M | 3.29M | 3.37M |
| Total Common Equity | 1.20B | 1.33B | 1.35B | 410.46M | 236.21M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.20B | 1.33B | 1.35B | 410.46M | 236.21M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.20B | 1.33B | 1.35B | 410.46M | 236.21M |
|
|
|||||
